Breast carcinoma originating from a silicone granuloma: a case report by unknown
Breast carcinoma originating from a silicone
granuloma: a case report
Nakahori et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Nakahori et al. World Journal of Surgical Oncology  (2015) 13:72 
DOI 10.1186/s12957-015-0509-6
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Nakahori et al. World Journal of Surgical Oncology  (2015) 13:72 
DOI 10.1186/s12957-015-0509-6CASE REPORT Open AccessBreast carcinoma originating from a silicone
granuloma: a case report
Ryoichi Nakahori1,2*, Ryuji Takahashi1,2*, Momoko Akashi1,2, Kana Tsutsui1,2, Shino Harada1,2,
Roka Namoto Matsubayashi1,2, Shino Nakagawa1,2, Seiya Momosaki2,3 and Yoshito Akagi4Abstract
Breast carcinoma rarely occurs in cases of foreign body granulomas following liquid silicone injection. Although
the Food and Drug Administration (FDA) banned the use of all silicone injection products in 1992, liquid silicone
injection for breast augmentation continues to be performed illegally. We herein report a case of breast carcinoma
following liquid silicone injection in a 67-year-old female.
A total of 45 years after liquid silicone injection, the patient had felt a breast mass in the right breast.
Mammography showed a smooth mass that retracted the right nipple. Due to the presence of a marked acoustic
shadow caused by the granulomas, evaluating the mass on ultrasonography was difficult. However, magnetic
resonance imaging (MRI) showed a lobulated mass under the right nipple. The mass exhibited low signal intensity
(SI) on T1-weighted images and intermingled high and low SI on T2-weighted images. Heterogeneous early
enhancement with central low intensity was noted on dynamic contrast-enhanced MRI. Several oval-shaped low SI
structures in the adipose tissue and disruption of the pectoralis major muscle were also observed. We diagnosed
the patient with invasive ductal carcinoma based on a stereotactic-guided Mammotome® (a vacuum-assisted biopsy
system manufactured by DEVICOR MEDICAL JAPAN, Tokyo, Japan) biopsy and subsequently performed mastectomy
and axillary lymph node dissection (with a positive result for the sentinel node biopsy). Histologically, invasive ductal
carcinoma was observed in the silicone granuloma.
The development of foreign body granulomas following breast augmentation usually makes it difficult to detect
breast cancer; thus, various devices are required to confirm the histological diagnosis of breast lesions. The
stereotactic-guided Mammotome® biopsy system may be an effective device for diagnosing breast cancer developing
in the augmented breast.
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Liquid silicone injection for breast augmentation was
initiated worldwide and in Japan in the 1940s [1,2].
However, due to complications such as inflammatory
changes and fibrosis, the use of liquid silicone for breast
augmentation has been decreasing [3,4]. In August 1991,
the Food and Drug Administration (FDA) prohibited the
marketing or sale of injectable liquid silicone for esthetic
purposes [5]. Notably, the FDA has never approved the
use of injections of liquid silicone for cosmetic treatment
in patients. In 1992, the FDA officially banned the use of* Correspondence: nakahori@kyumed.jp; ryuji@kyumed.jp
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However, liquid silicone injection for breast augmenta-
tion continues to be performed illegally, making it diffi-
cult to estimate the number of females who have
received this procedure [3,4,6]. We herein report a case
of breast carcinoma following liquid silicone injection in
a 67-year-old female.Case presentation
A 67-year-old female felt a breast mass in her right breast
and visited our hospital. She had received silicone oil in-
jection into bilateral breasts at 22 years of age. Mammog-
raphy showed a smooth mass that retracted the right
nipple (Figure 1a). Ultrasonography revealed a so-calledal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Mammography and ultrasonography. (a) Mammography showed a smooth mass that retracted the right nipple. (b) Ultrasonography
revealed a so-called ‘snowstorm’ appearance with diffuse hyperechogenic lesions and posterior shadowing.
a b
c d
Figure 2 Breast magnetic resonance imaging (MRI). (a) T1-weighted MRI showed a low signal intensity (SI) mass (3.5 × 3.2 × 4.0 cm in size)
that retracted the right nipple. Several oval-shaped low SI structures in adipose tissue and disruption of the pectoralis major muscle were also
observed (arrows). (b) The mass showed intermingled high and low SI on T2-weighted images. (c, d) Heterogeneous early enhancement with
central low intensity was noted on dynamic contrast-enhanced MRI (c: early phase, d: delay phase).
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Figure 3 Intraoperative findings. We performed mastectomy and
axillary lymph node dissection (a positive result for the sentinel node
biopsy). The intraoperative findings showed marked adipose
degeneration in the retromammary space and many white round
bodies indicating silicone granulomas.
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sions and posterior shadowing (Figure 1b). It was
difficult to distinguish between the silicone granuloma
and breast cancer using these modalities; therefore,
magnetic resonance imaging (MRI) was performed.
T1-weighted images showed a low signal intensity (SI)
mass (3.5 × 3.2 × 4.0 cm in size) that retracted thea
c
Figure 4 Resected specimens and histological findings. (a) The resecte
(b, c) Histologically, stromal invasion of invasive ductal carcinoma was obs
stain X4, c: HE stain X100). (d) Inflammatory granulomas and foreign bodyright nipple (Figure 2a). Several oval-shaped low SI
structures in the adipose tissue and disruption of the
pectoralis major muscle were also observed (Figure 2a).
The mass showed intermingled high and low SI on T2-
weighted images (Figure 2b), while heterogeneous early
enhancement with central low intensity was noted on
dynamic contrast-enhanced MRI (Figure 2c,d). On
diffusion-weighted images, the mass exhibited high SI
due to the restricted diffusion.
We investigated available approaches for diagnosing
this tumor histologically and consequently performed a
stereotactic-guided Mammotome® (a vacuum-assisted bi-
opsy system manufactured by DEVICOR MEDICAL
JAPAN, Tokyo, Japan) biopsy because the tumor was
clearly detectable on mammography. The most high-
density area of the tumor was targeted in order to obtain
tissue samples from the tumor. According to the histo-
logical findings of the biopsied specimens, we diagnosed
the patient with invasive ductal carcinoma and subse-
quently performed mastectomy and axillary lymph node
dissection (with a positive result for the sentinel node bi-
opsy). The intraoperative findings showed marked adi-
pose degeneration in the retromammary space and
many white round bodies, which indicated the presence
of capsulated silicone (Figure 3). The resected specimens
demonstrated a white and partially red lobulated mass
(3.4 × 2.7 cm in size) (Figure 4a).b
d
d specimens showed a white and partially red lobulated mass (arrows).
erved in the silicon granuloma (hematoxylin & eosin [HE] stain; b: HE
giant cells (arrows) were observed (HE stain X100).
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carcinoma was observed in the silicone granuloma
(Figure 4b,c), and inflammatory granulomas and foreign
body giant cells were also observed (Figure 4d). The
pathological diagnosis was as follows: scirrhous carcin-
oma, nuclear grade 3, positive for lymph node metastasis
(1/18), estrogen receptor-positive (95%), progesterone
receptor-positive (30%), human epidermal growth fac-
tor receptor 2 (HER2)-negative (score 1+ on immuno-
histochemistry), and a high Ki-67 index (35%). Four
cycles of treatment with EC (90 mg/m2 of epirubicin
and 600 mg/m2 of cyclophosphamide) were given as
adjuvant chemotherapy, and the patient currently re-
mains alive, without recurrence, at 10 months after the
surgery.
Discussion
As a result of liquid silicone injection to the breast,
many females develop inflammatory changes and granu-
lomas, which complicate breast cancer screening [7].
Mammography in these patients often shows numerous
bilateral round or oval masses with rim calcification,
while ultrasonography shows a ‘snowstorm’ appearance
with diffuse hyperechogenic lesions and posterior sha-
dowing characteristic of free silicone, ring-down artifacts
[8,9]. These radiographic findings make it difficult to de-
tect breast cancer in the early stage; thus, contrast-
enhanced MRI is beneficial for breast cancer screening
[10,11]. Many cases of breast carcinoma developing in
the augmented breast have been reported to date
[6,10-23]. Major cohort studies investigating the fre-
quency of breast cancer following breast augmentation
have reported rates ranging from 0.2% to 2.7% [24]. We
herein reported a case of breast carcinoma that devel-
oped in the augmented breast following liquid silicon in-
jection. Histologically, inflammatory granulomas and
foreign body giant cells were observed with stromal in-
vasion of invasive ductal carcinoma. Various histological
types of cancer have been reported after liquid silicone
injection in the previous literature [6,12,15,17,18,20-23].
Interestingly, there are two cases of squamous cell carcin-
oma following liquid silicone injection [15,17]. Handel
et al. mentioned that augmented patients present with a
statistically greater frequency of palpable lesions, with a
slightly greater risk of invasive tumors and an increased
likelihood of axillary lymph node metastases [13]. Despite
this observation, there are no statistically significant differ-
ences in the stage at diagnosis or the prognosis between
augmented and non-augmented patients [13,19]. How-
ever, most of the augmented patients in these studies
received a bag prosthesis or paraffin injection. There-
fore, the details of the histological and clinical charac-
teristics of breast cancer following liquid silicone injection
have not been thoroughly investigated to date.Performing the accurate detection and evaluation of
breast carcinoma in cases of foreign body granulomas
is difficult, as the images are severely affected by arti-
facts caused by the granulomas. Therefore, various de-
vices are required to confirm the histological diagnosis
of breast cancer. In the present study, we performed a
stereotactic-guided Mammotome® biopsy because the
tumor was detectable on a mammogram in this case.
Importantly, the early diagnosis of breast cancer resulted
in successful curative surgery and subsequent adjuvant
chemotherapy. The stereotactic-guided Mammotome®
biopsy system may be an effective device for diagnosing
breast cancer developing in the augmented breast.Conclusions
In conclusion, obtaining an early diagnosis of breast car-
cinoma originating from silicone granulomas is difficult.
The stereotactic-guided Mammotome® biopsy system
may be an effective device for diagnosing breast cancer
developing in the augmented breast.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent form is available
for review from the Editor-in-Chief of this journal.
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